Clinical Trials
75 trialsGRECCAR 5
University Hospital, Bordeaux
HERKULES-3
Erasca, Inc.
Dressing
Fudan University
A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
St. Jude Children's Research Hospital
REFYO-R
Hospices Civils de Lyon
EmoVie_K2
University Hospital, Lille
ALLAN
Lund University Hospital
Phase 1 Trial of AZD6422 in CLDN18.2+ GI Tumors
Peking University
ARROW
Hoffmann-La Roche
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Revolution Medicines, Inc.
TheraSphere Post-Approval Study to Calculate the Radiation-absorbed Dose of Tc-99m MAA.
Boston Scientific Corporation
A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OPTIMA
Imunon
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
Trial of NanoPac® in Subjects With Locally Advanced Pancreatic Adenocarcinoma
NanOlogy, LLC
MMOT
University Medical Center Groningen
Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction
Catalysis SL
Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma
Catalysis SL
A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer
Sumitomo Pharma America, Inc.
CanStem303C
Sumitomo Pharma America, Inc.
CanStem111P
Sumitomo Pharma America, Inc.
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
Sumitomo Pharma America, Inc.
HEAIS001
Zhejiang Hospital
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Mayo Clinic
apact
Celgene
Evaluation of Ocoxin-Viusid® in Advanced Pancreatic Adenocarcinoma
Catalysis SL
A Multicenter Clinical Trial of Stool-based DNA Testing for Early Detection of Colon Cancer in China
Creative Biosciences (Guangzhou) Co., Ltd.
Retrospective Analysis of Colorectal Cancer Screening Results
Creative Biosciences (Guangzhou) Co., Ltd.
ALTER-C-002
Zhejiang University
A Study to Evaluate the Safety and Efficacy of the Use of ME-APDS During Colonoscopy
Magentiq Eye LTD
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Syndax Pharmaceuticals
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
Syndax Pharmaceuticals
Association Between Perioperative Nutritional Status and Surgical Outcome in Digestive System Cancer Patients
Mahidol University
Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Everolimus in Combination With Imatinib in Patients With Glivec Refractory/Resistant Gastrointestinal Stromal Tumors
Novartis
Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
NanOlogy, LLC
SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Prophylactic Cholecystectomy is Not Mandatory in Patients Candidate to the Resection for Small Intestine Neuroendocrine Neoplasms: a Propensity Score-matched and Cost-minimization Analysis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
EVALYMPH
Centre Hospitalier Universitaire de Saint Etienne
CLEAR-C
Zhejiang University
Transcutaneous Electrical Acupoint Stimulation for Postoperative Cognitive Dysfunction
Subei People's Hospital of Jiangsu Province
PNASIT
Jinling Hospital, China
PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer
Isofol Medical AB
GIGENAS
Jinling Hospital, China
An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer
Isofol Medical AB
PALAESTRA
Lund University Hospital
PREDICARE
LEO Pharma
Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Colorectal Cancer Screening in a Community Health Setting
University of Pennsylvania